All In Biotech

Drug Trial Radar · NCT07089043

A Study in Subjects With Neurogenic Orthostatic Hypotension

A Single-Blind Dose-Ranging Study in Subjects With Neurogenic Orthostatic Hypotension to Evaluate the Effect of CST-3056 on Symptoms and Signs of Orthostatic Hypotension

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

12

Actual

Start

Sep 12, 2025

Primary completion

Sep 24, 2026

Study completion Oct 2026

Sponsor

Lead sponsor
CuraSen Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jul 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).

Conditions

  • Neurogenic Orthostatic Hypotension

Interventions

  • CST-3056Drug

    Administered as an oral solution

  • PlaceboDrug

    Administered as an oral solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Standing Systolic Blood PressureTime frame: Baseline and 1, 2, 3, and 4 hours post-dose on Days 1 to 4

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • CuraSen Investigational Site

    Scottsdale, Arizona

  • CuraSen Investigational Site

    Farmington Hills, Michigan

  • CuraSen Investigational Site

    Eatontown, New Jersey

  • CuraSen Investigational Site

    New York, New York

  • CuraSen Investigational Site

    Nashville, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.